Martin Brecher, MD
- 12Articles
- 69.9KReads
- 1999–2010Active
- 52Collaborators
- 1.5KCitations
About
Martin Brecher, MD, has published extensively on the clinical pharmacology and treatment of psychiatric disorders including schizophrenia, schizoaffective disorders, major depressive disorder, bipolar disorder, and dementia. His work focuses on the efficacy and safety of atypical antipsychotics such as quetiapine, lithium, and risperidone, as well as their metabolic and neurological effects. Brecher’s research spans randomized, double-blind, placebo-controlled trials and studies addressing psychopharmacology in elderly populations. His publications appeared from 1999 to 2010 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
